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Abstract
A deuterium-deuterium (DD) neutron generator–based neutron activation analysis (NAA) system 
has been developed to quantify metals, including manganese (Mn), in bone in vivo. A DD neutron 
generator with a flux of up to 3*109 neutrons/second was set up in our lab for this purpose. 
Optimized settings, including moderator, reflector, and shielding material and thickness, were 
selected based on Monte Carlo (MC) simulations conducted in our previous work. Hand phantoms 
doped with different Mn concentrations were irradiated using the optimized DD neutron generator 
irradiation system. The Mn characteristic γ-rays were collected by an HPGe detector system with 
100% relative efficiency. The calibration line of the Mn/calcium (Ca) count ratio versus bone Mn 
concentration was obtained (R2 = 0.99) using the hand phantoms. The detection limit (DL) was 
calculated to be about 1.05 μg/g dry bone (ppm) with an equivalent dose of 85.4 mSv to the hand. 
The DL can be reduced to 0.74 ppm by using two 100% HPGe detectors. The whole body 
effective dose delivered to the irradiated subject was calculated to be about 17 μSv. Given the 
average normal bone Mn concentration of 1 ppm in the general population, this system is 
promising for in vivo bone Mn quantification in humans.
1. Introduction
Manganese (Mn) is an essential trace element in the human body. Adverse health effects 
occur when body Mn storage is either too low or too high. Mn deficiency is generally not 
recognized among humans because of their diverse diets. Yet, Mn overexposure is common. 
Occupational exposure to Mn often takes place in mining, welding, steel industry, and other 
industrial settings (Crossgrove and Zheng, 2004). Environmental exposure to Mn has been 
reported in the uses of Mn-containing products (e.g. Mn-based pesticides), contamination in 
drinking water and food (Bouchard et al., 2011), and the use of Mn compounds in gasoline 
(Butcher et al., 1999). There are also reports of excessive Mn exposure among ephedron 
drug abusers (Yildirim et al., 2009).
With excessive Mn deposition, chronic Mn toxicity can be evidenced in cardiovascular, 
liver, reproductive, and developmental problems, although it is mainly seen to affect lung 
tissue and the central nervous system (Crossgrove and Zheng, 2004, Jiang and Zheng, 2005). 
Indeed, workers exposed to Mn have reported various neurological disorders, including poor 
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eye-hand coordination, reduced cognitive flexibility, tremors, and poor postural stability 
(Levy and Nassetta, 2003, Rodier, 1955, Wennberg et al., 1991). In severe cases, a 
devastating neurological impairment called “manganism” occurs (Goldhaber, 2003, 
Lucchini et al., 2009, Martin, 2006, Santamaria et al., 2007, Racette et al., 2012). At lower 
levels, Mn exposure causes more subtle neurological disorders (Kim et al., 2011, Zoni et al., 
2012, Laohaudomchok et al., 2011). The symptoms of chronic Mn toxicity usually become 
progressive and are irreversible, reflecting permanent damage to neurological structures 
(Aschner et al., 2007, Jiang et al., 2006).
Mn levels in the human body have been estimated from blood, serum, urine, hair, and 
toenails. There is evidence that these biomarkers are useful in some ways. For instance, 
blood, hair, and toenail Mn concentrations were found to be higher in occupationally 
exposed workers than in matched controls in different studies (Myers et al., 2003, Zheng et 
al., 2011). However, these biomarkers are of little use for long-term cumulative exposure 
assessment. Analyses of whole blood Mn were found to be highly variable among human 
population and are not significantly correlated with Mn-induced neurotoxicity (Santos et al., 
2013). This is due primarily to a short half-life of Mn in blood and large intracellular 
distribution (Zheng et al., 2000). High variability was also observed for Mn concentrations 
in toenails and hair (Wongwit et al., 2004, Bader et al., 1999). In addition hair and nail 
samples are subject to external contamination. Recently, MRI imaging technologies have 
been developed to quantify Mn in brain tissue using the signal intensity in the basal ganglia 
region (Dydak et al., 2011, Jiang et al., 2007). While it is advantageous to directly relate Mn 
exposure to brain function, this technology again has the limitation that Mn is released from 
the brain after a short time, and hence it only reflects recent Mn exposure. Overall, the lack 
of a reliable cumulative exposure biomarker limits the capacity for epidemiologic studies to 
detect a relationship between Mn exposure and neurodegeneration, especially for low-level 
exposures and their more subtle neurological effects.
On the other hand, bone has much greater potential to be a reliable biomarker for cumulative 
Mn in the body. Schroeder et al. (1966) reported an average Mn concentration of 2 μg/g in 
bone ash, which gives rise to about 32.5% of body Mn being contained in bone, according to 
our previous calculation (Liu et al., 2013). International Commission on Radiological 
Protection (ICRP) reported about 40% of body Mn in bone (ICRP, 1975). A recent study 
shows that the average half-life of Mn in bone is 147 days in rats that are chronically 
exposed to Mn-contaminated drinking water (Zheng et al., 2014), which is much longer than 
its half-life in other organs. The same researchers also show a significant correlation 
between brain Mn and bone Mn in rats fed with Mn-contained water (Hong et al., 2013). 
Hence, it is logical to postulate that bone is one of the main long-term storage organs for Mn 
in humans, and that bone Mn is a relevant and valuable biomarker for Mn neurotoxicity.
Our group has developed novel transportable neutron activation analysis (NAA) technology 
to quantify Mn in bone in vivo. In our previous work (Liu et al., 2013), the methodology and 
feasibility of developing such a system were investigated using Monte Carlo simulations and 
a deuterium-tritium (DT)–based neutron generator system. The purposes of the current study 
were: (1) to set up a DD-based neutron generator system; (2) to characterize, test, and 
optimize the system for in vivo Mn quantification using Monte Carlo simulations and 
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experiments; (3) to improve the system by modifying the moderator/reflector/shielding 
system; (4) to set up and use a 100% high efficiency HPGe detection system to measure the 
Mn γ-rays produced by neutron activation, and to reduce the detection limit (DL) of the 
system for in vivo bone Mn quantification.
2. Materials and methods
2.1. Monte Carlo simulation
This project used the Monte Carlo N-Particle (MCNP) code, which was developed by Los 
Alamos National Laboratory (LANL). MCNP code uses the Monte Carlo method to 
simulate the propagation of particles, including neutrons and photons (http://
mcnp.lanl.gov/). To the benefit of our project, the new version of the MCNP code contains 
the latest cross-sectional data and is able to tally the neutron flux, activation, and radiation 
dose based on user-defined source/moderator/reflector/shielding geometry and composition. 
At thermal neutron energies, the binding of the scattering nucleus in a solid, liquid, or gas 
affects the cross-section and the angular and energy distributions of the scattered neutrons. 
When available, the S(α, β) data were included to better simulate thermal neutron 
interaction. This project used MCNP5 version 1.6 of the code, and all input files were 
checked with the VISED X_24E visual editor for geometric consistency. All the results have 
uncertainties of less than 5%.
2.2. DD neutron generator and neutron flux
The neutron generator used in this project was a customized DD-109 manufactured by 
Adelphi Technology Inc. (Redwood, CA). The main components of a DD neutron generator 
are the ion source, ion extractor, beam target, power supply/electronics rack, and heat 
exchanger. Figure 1 shows the DD neutron generator installed in our lab, while Figure 2 is a 
schematic plot of the generator head with dimensions provided by Adelphi. A deuterium 
(D2) gas bottle was mounted beside the table to provide a continuous supply of deuterium 
gas when the system was operating. The gas line was highly vacuumed by a roughing pump 
and a more rigorous turbo pump. Like all DD neutron generators, the DD-109 employed in 
this study used the DD fusion reaction (2D + 2D → 4He → 3He + n) and was driven by an 
ion beam supplied by a radio frequency–driven ion source.
The target for this project was made from titanium-coat ed copper. To maximize the neutron 
production and lifetime of the target, the temperature of the titanium surface was maintained 
by active cooling. The V-shaped target was also designed for efficient cooling, as shown in 
Figure 2. To shield the bremsstrahlung x-rays generated by the electrons emitted back to the 
plasma source from the primary ion interaction at the titanium target, 3 mm thick lead was 
placed around the generator head.
Neutron flux of up to 3 × 109 neutrons/second can be produced with this generator, 
depending on the acceleration voltage and the ion current. The voltage varies from 80 kV to 
125 kV, while the current varies from 10 mA to 13 mA. The true neutron flux can be 
determined by a lightweight NSN3 neutron survey meter (Fuji Electric Corp.) coupled with 
MC simulation results. This neutron survey meter uses mixed methane and nitrogen gas to 
measure fast neutrons based on elastic scattering reactions and thermal neutrons based 
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on 14N(n,p) reactions. The neutron ambient dose equivalent can then be obtained, taking into 
account the ICRP 74 (ICRP, 1997) neutron flux-to-dose equivalent rate conversion factors 
(Nunomiya et al., 2011). The NSN3 dosimeter’s mono-energetic and continuous energy 
response is within 50% difference from thermal to 15 MeV neutrons.
2.3. Moderator/reflector/shielding system and experimental setup of the DD neutron 
generator
Based on the MC simulation results presented for our past work (Liu et al., 2013), an 
optimized moderator/reflector/shielding system was built to create a cavity for the 
irradiation of human hands. Our previous paper showed that an optimized configuration 
consists of 5 cm of paraffin as the moderator and >10 cm of paraffin as the reflector. In the 
system used in the current study, polyethylene was used instead of paraffin because paraffin 
is flammable. This will not significantly impact the results, however, since the composition 
of paraffin and polyethylene are similar, as shown in our paper cited above. Specifically, 5 
cm of polyethylene was used as the moderator; 10 cm of polyethylene was used as the 
reflector; and the shielding structure was made of >30 cm of polyethylene. The neutron dose 
outside of the shielding was measured to be 2–5 mR/hour based on this configuration. 
Figure 3 shows the experimental setup of the DD neutron generator with the polyethylene 
moderator/reflector/shielding system, with part of the shielding removed to present a better 
view of the human hand cavity.
Work is in progress to build a more compact shielding structure with a tighter fit around the 
generator head except on the side where the hand will be irradiated. Our most recent 
experimental and simulation results (not presented in this paper) also show that the neutron 
spectra are significantly altered as the size of the gaps between the moderator blocks and 
reflector blocks changes. In addition, graphite has been demonstrated to be a more efficient 
material for a reflector. More work continues to be conducted to further optimize this 
moderator and reflector configuration.
2.4. Manganese-doped human hand phantoms
Five Mn-doped hand phantoms were manufactured and used in this study. The Mn 
concentrations in the phantoms were 0, 5, 10, 15, and 20 μg Mn/g bone (which corresponds 
to 0, 22, 44, 66, and 88μg Mn/g Ca). Other elements in bone that might interfere with the 
spectrum through neutron activation were also added to the phantoms to better simulate real 
human hands. The concentration of each element in the bones of the hand was calculated 
based on ICRP publication 23’s gross and element content of the cortical bone of a reference 
human male (ICRP, 1975). Table 1 lists all the elements included and the weight of their 
chemical compounds.
All the chemical compounds were first diluted in distilled water before being added to the 
matrix to ensure a better homogeneity of the elements in the phantoms. The phantoms were 
then dried in the hood for one day. These phantoms were bone-equivalent phantoms, but 
they did not have the shape of a human hand. More work is in progress to manufacture 
hand-shaped phantoms encased in soft tissue.
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2.5. In vivo neutron activation analysis
With the system shown in Figure 3, Mn concentrations present in the hand bone of a human 
subject can be noninvasively determined using in vivo neutron activation analysis (IVNAA). 
As described in our previous paper (Liu et al., 2013), during neutron activation, 
characteristic γ-rays are produced following the radioactive decay of the product from 
an AX(n,γ)(A+1)X nuclear reaction. By collecting the characteristic γ-rays and calculating 
their total counts, the concentration of the element of interest can be determined. For Mn 
quantification, neutrons interact with 55Mn and produce 56Mn with a thermal neutron 
capture cross section of 13.3 barns. Unstable 56Mn atoms decay to 56Fe, which emits 847 
keV characteristic γ-rays. These γ-rays can then be collected by a γ-ray detection 
system. 56Mn’s relatively long half-life of 2.58 hours allows for delayed γ counting. The 
calculation for the intensity of the characteristic γ-rays can be found in our previous paper.
Using the fm4 card in MCNP5, the probability of the activated nucleus can be obtained. 
Together with the activation equation, the simulated total γ-ray counts can be expressed as:
(1)
where CTotal is the γ-ray counts that will be measured by the γ-ray detector; N is the total 
activated 56Mn number from the simulation result; γ is the branch ratio of the γ-rays; ε is the 
absolute detection efficiency; S(= 1 − e−λti) is the saturation factor with ti representing 
irradiation time; D(= e−λtd) is the decay factor with td representing decay time; and C(=1 − 
e−λtc)/λ is the counting factor with tc representing counting time. CTotal can be compared to 
experiment results to test the consistency of the simulation and experimental results.
The irradiation, decay, and counting time can also be optimized to determine the best time 
sequence. We selected 10 minutes of irradiation time to allow for an acceptable dose to the 
hand; 5 minutes of decay time to collect a spectrum for calcium (Ca); and 30 minutes of 
measurement time in consideration of the time that a human subject could be expected to sit 
relatively still to take the measurement. This time sequence can be further improved in 
future work.
A sample of pure gold (Au) foil and an Mn-doped hand phantom were irradiated by the DD–
based neutron generator system and then measured by an HPGe γ-ray detection system. The 
same scenarios were also simulated using the MC simulation model. The results from the 
MC simulations and the experiments were then compared. This is to validate the results 
from MC simulations.
2.6. HPGe detector and gamma spectrum analysis
A high-efficiency HPGe detector was used in this study for γ-ray detection. It is a model 
GMX90P4-ST HPGe detector with a relative efficiency of 100%. The detector is cooled by 
an electromechanical cooler (Ortec, Oak Ridge, TN). Lead bricks were mounted around the 
detector to reduce the background signal. The DSPEC Plus digital box was used for signal 
processing, and Maestro γ-ray spectroscopy software was used for signal collection. The 
efficiency of the system was calibrated using a multi-radionuclide calibration source with 
known activities. The efficiency equation was obtained as: efficiency =1.0548 × 
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energy(keV)−0.688 at 5 cm away from the detector’s window. Figure 4 shows two high-
efficiency detectors with a possible configuration of how a hand could be measured. 
Notably, only one of these detectors was used in this project because the other one was 
experiencing some technical problems.
Gamma-ray spectrum analysis was performed using an in-house fitting procedure 
programmed in the commercial software package IGOR Pro 6 (Wave Metrics, Inc., Lake 
Oswego, OR). The γ-ray peaks were fitted using the Gaussian function for net counts and an 
exponential function to account for background.
2.7. System calibration and the Mn/Ca ratio
The most straightforward way to calibrate the system for Mn quantification is to build a 
calibration line of 56Mn γ-ray counts versus Mn concentration. However, this count would 
be affected by the thermalization of the neutrons within the samples, the thickness of the soft 
tissue in the hand, the weight of the hand, and the slightly different irradiation geometries. 
To account for these differences, Mn γ-ray counts can be normalized to Ca γ-ray counts, 
since the concentration of Ca is relatively constant in bone. Thus, a calibration line 
representing the Mn/Ca ratio versus Mn concentration was established.
3. Results
3.1. Neutron flux
As described above, neutron flux can be determined using a neutron generator coupled with 
MC simulation results. Figure 5 shows a cross-sectional plot of the neutron activation 
system used in the MC simulation model. To produce approximately 109 neutrons per 
second, the magnetron was set to 5 kV and 80 mA; the accelerator was set to 120 kV and 16 
mA; and the D2 gas flow was set to 1.2 standard cubic centimeters per minute (SCCM) with 
a pressure of ~5.0 mTorr (~4.7 mTorr in operation). The neutron dose, as measured from 
one side by the NSN3 dosimeter when the shielding was open, was 948.6 mRem/h at 109 
cm away from the neutron source. The NSN3 neutron survey meter measures ambient 
neutron dose equivalent H*(10), so ICRP-74 (ICRP, 1997) neutron flux-to-dose equivalent 
rate conversion factors were employed in MCNP5 input files to obtain a dose measure that 
equaled the ambient dose equivalent. The simulated neutron dose for the neutron flux of 1 × 
109 neutrons/second at the 109 cm was 1374.5 mRem/h. Given the measured dose of 948.6 
mRem/h at the same spot, the actual neutron flux was calculated to be about 7 × 108 
neutrons/second.
3.2. Neutron activation using MC simulations and experiments
With the parameters and settings described above, and in order to assess how the MC 
simulation results compared to experimental results, a 0.121 gram sample of Au foil was 
irradiated in the irradiation cavity for 10 minutes, decayed for 2 hours, and measured for 1 
hour with the HPGe γ-ray detection system. Additionally, a 20 ppm Mn-doped hand 
phantom was also irradiated in the irradiation cavity for 10 minutes, decayed for 10 minutes, 
and measured for 30 minutes with the HPGe detection system.
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The Au γ-ray counts calculated from the experiment was 818.2±27.6, compared to the 
simulation result of 809.4±1.1. The Mn γ-ray counts calculated from the experiment, based 
on the net peak counts from the spectrum analysis was 238.8±24.8, compared to the 
simulation result of 141.2±0.2 taking into account the detector efficiency. Several factors 
might have contributed to the discrepancy for Mn measurement and simulation, with the 
main factor to be the difficulty to determine the detector efficiency for the measurement of 
the hand phantom (in contrast, it is much easier to obtain an accurate detector efficiency for 
the measurement of Au foil); these factors are considered in the discussion section.
3.3. Data collection, Mn spectrum, Mg interference, and the detection limit
Mn-doped hand phantoms with Mn concentrations of 0, 5, 10, 15, and 20 ppm were placed 
in the sample cavity and irradiated for 10 minutes, decayed for 5 minutes, and measured by 
the HPGe detector for 30 minutes. The spectrum collected from the 5 ppm phantom is 
illustrated in Figure 6. With an energy resolution of 2.0 keV at 1.33 MeV, the peak of Mn γ-
ray at 847 keV can be clearly seen. The background in that energy range is mainly from 
Compton scattering and is relatively low. An enlarged Mn peak is shown at the top right of 
the figure. A magnesium (Mg) γ-ray peak at 844 keV is also observed from the spectrum. 
Although the Mg concentration in the hand phantoms is much greater than the Mn 
concentration, as shown in Table 1, the interference of the Mg γ-ray peak is minimal, even 
with a Mn concentration at as low as 5 ppm, as shown in Figure 6.
The detection limit (DL) of the system was calculated based on the measurements taken 
from the Mn-doped phantoms. It was calculated using the following formula:
(2)
where background is the background counts under the Mn γ-ray peak for the 0 ppm 
phantom, and C (counts/ppm) is the slope of the regression line of Mn counts versus Mn 
concentration. The energy range of the background was estimated to be 4 sigma of the Mn γ-
ray Gaussian peak, which covers 96% of the peak counts. Sigma was estimated from the 
fitting program built into IGOR. The DL calculated from equation 2 was 1.05 ppm.
3.4. Bone Mn calibration line
The spectra for all the Mn-doped hand phantoms (0, 5, 10, 15, and 20 ppm) were analyzed. 
The net peak counts for Mn and Ca were calculated using our in-house peak fitting program. 
The Mn/Ca ratio versus Mn concentration was then plotted, as shown in Figure 7. The R-
square for the correlation was 0.99, which indicates that the phantoms are a good 
configuration and that the calibration procedure works.
3.5. Radiation dose
The radiation dose to a human hand was calculated using MC simulations. After 10 minutes 
of irradiation at a neutron flux of 7 × 108 neutrons/second, the equivalent dose to a hand was 
found to be 85.4 mSv. The dose outside of the shielding was calculated using MC 
simulations and measured using the NSN3 neutron meter. The simulated dose rate was 3.88 
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mRem/hour or 38.8 μSv/hour with the neutron flux of 7 × 108 neutrons/second, which gives 
rise to a dose of about 6.5 μSv for 10 minutes of irradiation. The measured dose rate was 
about 3.85 mRem/hour or 38.5 μSv/hour, which is very close to the simulated value. The 
weight of a human hand accounted for about 1.25% of the weight of the whole body. The 
tissue weighting factor for the more sensitive organs in hand, skin and bone surface, is 0.01. 
Taking into account the tissue weighting factor, the whole body effective dose was 
calculated to be 85.4×103×0.01×0.0125+6.5 = 17 μSv. For comparison, the whole body 
effective dose from a standard AP chest x-ray is about 100 μSv. The neutron spectrum inside 
the hand irradiation cavity is complex, and work is being conducted to obtain an accurate 
neutron dose inside the hand cavity using experiments to validate the hand dose calculated 
by simulation.
4. Discussion and future work
In this project, the neutron yield was calculated based on MC simulations and NSN3 neutron 
detector results. From the previous work of Nunominya et al. (2011), we can confirm that 
this neutron detector is accurate at measuring dose from neutrons with energy ranging from 
400 keV to 10 MeV, but can largely underestimate the neutron dose from 8 keV to 250 keV. 
With one side of the shielding open, the major contributor of the neutron dose was from 2.45 
MeV neutrons (accounting for over 90% of the total neutron spectrum, as per the 
simulation). It was thus concluded that the detector responded correctly to the neutron field, 
and that the neutron flux of 7 × 108 neutrons/second should be very close to the true flux in 
the setting we used.
The counts of Au γ-rays obtained from the MC simulation and from the experiment are the 
same within the error, while the counts of Mn γ-rays obtained from the MC simulation and 
from the experiment differed by a factor of 1.7. This discrepancy could have resulted from 
difference between the Au and Mn samples. Au sample is a foil, while Mn sample is a 
rectangular shaped bone equivalent phantom. We were not able to find a standard source 
with the same shape as the Mn-doped hand phantom and hence the detector efficiency could 
easily make a difference of a factor of 2. However, this should not affect the calculations of 
the detection limit or the calibration line, because the detector efficiency was not required in 
these calculations. However, more work will be done to obtain a more accurate detector 
efficiency curve for the Mn-doped phantoms.
Our work confirmed that a compact DD neutron generator–based NAA system can be used 
for the noninvasive quantification of Mn in bone in vivo. The detection limit was calculated 
to be 1.05 ppm, which is comparable to the level of Mn in the general population. With the 
parameters we used, the hand equivalent dose for 10 minutes of irradiation at the neutron 
flux of 7 × 108 neutrons/second was calculated to be 85.4 mSv. To comply with the ALARA 
principle, a hand equivalent dose of less than 50 mSv is desirable. By scaling down the 
irradiation time from 10 minutes to 5.85 minutes, the hand dose can be reduced to 50 mSv, 
although the DL would thereby increase by a factor of 1.7 to 1.79 ppm. However, several 
improvements can also be made to lower the DL. First, the moderator/reflector/shielding 
system can be further improved to generate more thermal neutrons within the acceptable 
dose range. Second, an additional high-efficiency HPGe detector can be used to cover a 
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better geometry of γ-ray detection; specifically, the use of two HPGe detectors (as shown in 
Figure 4) would reduce the DL to 1.27 ppm with 5.85 minutes of irradiation time, or to 0.74 
ppm with 10 minutes of irradiation time. Third, the irradiation, decay, and measurement 
time can be further optimized.
Work has been conducted by other groups using a laboratory-based accelerator to quantify 
metals in bone in vivo (Aslam et al., 2009, Pejovic-Milic et al., 2009). The main advantage 
of our system is that it utilizes a compact DD neutron generator, which greatly reduces the 
necessary space and resulting complications that come with using a large accelerator. 
Considering that the eventual goal of developing this technology is to use it in human 
studies, the transportability of our system makes it a more practical approach.
Our next step is to validate the technology using a human study population and to use the 
data collected by the system to investigate the association between cumulative Mn 
exposures and various health outcomes. Other future work includes optimizing and 
validating the system for the in vivo quantification of other elements. Elements with a 
relatively high thermal neutron capture cross-section are the most promising for our 
application, although elements that accumulate in relatively high concentrations in the 
human body can also be considered.
5. Conclusion
A compact DD neutron generator-based NAA system has been set up in our laboratory 
based on our previous feasibility study. The present work shows that the system is capable 
of quantifying Mn in hand bone with a detection limit of 0.74 ppm when using two 100% 
high-efficiency HPGe detectors. To achieve this sensitivity, the hand would need to be 
irradiated at a neutron flux of 7 × 108 neutrons/second for 10 minutes, which would give rise 
to an equivalent hand dose of 85.4 mSv and a whole body effective dose of 17 μSv. This 
system is now ready to be tested in a human study to quantify Mn in bone for cumulative 
Mn exposure assessment.
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Schematic plot of DD neutron generator head
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Neutron activation analysis system with moderator/reflector/shielding
Liu et al. Page 14















Liu et al. Page 15














Cross-sectional plot of the NAA system in the MC simulation model
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Gamma-ray spectrum of a bone-equivalent phantom doped with 5 ppm Mn
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Mn/Ca versus Mn concentration
Liu et al. Page 18






































































































































































































Physiol Meas. Author manuscript; available in PMC 2015 September 01.
